V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320003451 | 320002084 | 1.66 | 50 | Neo-adjuvant (N) | 2017-12-21 | 2017-12-21 | IVADo | 02 | N | 320022679 | GEMCITABINE |
| 320003452 | 320002085 | 1.69 | 46.2 | Adjuvant (A) | null | 2014-12-10 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | 320022680 | CVP R |
| 320003453 | 320002085 | 1.84 | 71.7 | Palliative (P) | 2013-03-17 | 2013-03-23 | Cisplatin + Pemetrexed | 2 | null | 320022680 | CAPE + CARBOPLATIN + CETUXIMAB |
| 320003454 | 320002086 | 1.77 | 86 | Palliative (P) | 2016-12-05 | 2016-12-05 | Bortezomib + Cyclophos + Dex | 2 | N | 320022691 | CISPLATIN + FLUOROURACIL + RT |
| 320003455 | 320002087 | 1.61 | 56 | Adjuvant (A) | 2015-12-27 | 2016-01-26 | Mitomycin Intravesical | null | N | 320022692 | VISMODEGIB |
| 320003456 | 320002087 | 1.72 | 77.4 | Curative (C) | 2014-02-15 | 2014-03-01 | BCG Intravesical | 02 | N | 320022692 | CARBOPLATIN + RT |
| 320003457 | 320006347 | 1.61 | 134 | Palliative (P) | null | 2017-07-17 | EVEROLIMUS | N | N | 320022701 | CARBOPLATIN + ETOPOSIDE |
| 320003458 | 320002088 | 1.56 | 82 | Palliative (P) | 2015-07-10 | 2015-07-10 | IMATINIB | 02 | N | 320022708 | MITOMYCIN INTRAVESICULAR |
| 320003459 | 320002088 | 1.7 | 68.2 | Palliative (P) | 2014-04-02 | 2014-04-11 | CETUXIMAB + CISPLATIN + FU | N | N | 320022708 | CAPECITABINE + OXALIPLATIN |
| 320003460 | 320002089 | 1.77 | 94.6 | Curative (C) | 2017-07-30 | 2017-08-05 | BCG Intravesical | 02 | N | 320022730 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320003461 | 320002090 | 1.71 | 71 | Palliative (P) | 2016-05-31 | 2016-06-30 | CARBOPLATIN + RT | N | N | 320022732 | CETUXIMAB + RT |
| 320003462 | 320002091 | 1.75 | 97.4 | Curative (C) | 2015-07-30 | 2015-08-17 | MITOMYCIN | 02 | N | 320022733 | CETUXIMAB + RT |
| 320003463 | 320002092 | null | null | Neo-adjuvant (N) | 2015-07-18 | 2015-07-28 | Carboplatin + Etoposide iv&po | N | N | 320022738 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320003464 | 320002093 | 1.7 | 82.4 | Neo-adjuvant (N) | 2013-12-03 | 2013-12-03 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 2 | N | 320022739 | OXALIPLATIN + MDG |
| 320003465 | 320002093 | 1.68 | 66.6 | Adjuvant (A) | 2015-03-10 | 2015-03-10 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 320022739 | DOCETAXEL |
| 320003466 | 320002094 | 1.74 | 73 | Adjuvant (A) | 2016-03-15 | 2016-03-15 | BCG Intravesical | N | N | 320022743 | CARBOPLATIN + RT |
| 320003467 | 320005019 | null | 81.8 | Palliative (P) | 2016-06-11 | 2016-06-11 | Capecitabine (14 days)+Carboplatin | N | N | 320022746 | CAPECITABINE + CISPLATIN |
| 320003468 | 320005019 | 0 | 66.8 | Palliative (P) | 2013-11-26 | 2013-12-14 | Cisplatin + Pemetrexed | N | N | 320022746 | FLUOROURACIL |
| 320003469 | 320002095 | 1.59 | null | Palliative (P) | null | 2015-09-23 | Capecitabine (21days) + Carboplatin | N | N | 320022750 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 320003470 | 320002096 | 1.67 | 69.8 | Neo-adjuvant (N) | 2014-11-17 | 2014-12-04 | CVP R | N | N | 320022756 | SORAFENIB |
| 320003471 | 320002097 | 1.76 | null | Curative (C) | 2014-06-15 | 2014-06-15 | PEMBROLIZUMAB | N | N | 320022758 | POUT TRIAL |
| 320003472 | 320002098 | 1.66 | 61.1 | Palliative (P) | 2016-10-23 | 2016-11-03 | CISPLATIN + GEMCITABINE | 02 | N | 320022766 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320003473 | 320002099 | 1.66 | null | Curative (C) | 2017-05-06 | 2017-05-13 | Carboplatin + Etoposide IV 3 day | N | N | 320022776 | EOX |
| 320003474 | 320002100 | 1.7 | 63 | Palliative (P) | null | 2017-03-12 | PEMBROLIZUMAB | N | N | 320022777 | CISPLATIN + DOCETAXEL |
| 320003475 | 320005020 | null | null | Curative (C) | 2017-06-21 | 2017-07-01 | FLUOROURACIL + IRINOTECAN | N | Y | 320022778 | CISPLATIN + PEMETREXED |
| 320003476 | 320002101 | 1.6 | 78.5 | Palliative (P) | 2013-06-30 | 2013-07-08 | ECX | null | null | 320022797 | CARBO + FLUOROURACIL |
| 320003477 | 320002102 | 1.69 | 57.5 | Palliative (P) | null | 2014-07-28 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 320022802 | CARBOPLATIN + RT |
| 320003478 | 320002102 | 1.67 | 49.8 | Not known (9) | 2018-07-10 | 2018-07-10 | CARBOPLATIN + ETOPOSIDE | N | null | 320022802 | PACLITAXEL |
| 320003479 | 320002103 | 1.57 | 59.2 | Adjuvant (A) | null | 2013-05-29 | Carboplatin + Liposomal Doxorubicin | null | null | 320022816 | CISPLATIN + GEMCITABINE |
| 320003480 | 320002104 | 1.78 | 70 | Neo-adjuvant (N) | 2017-01-31 | 2017-02-13 | IMATINIB | N | N | 320022821 | BCG |
| 320003481 | 320002105 | 1.66 | 73 | Palliative (P) | null | 2014-05-29 | Trial Unspecified | Y | null | 320022825 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320003482 | 320005022 | 1.84 | null | Palliative (P) | 2016-04-03 | 2018-01-26 | Cisplatin + Vinorelbine (IV) | 2 | N | 320022826 | TRIAL |
| 320003483 | 320005022 | null | 69.5 | Palliative (P) | 2015-06-08 | 2015-06-23 | Carboplatin + Etoposide IV 3 day | N | N | 320022826 | TEMOZOLOMIDE |
| 320003484 | 320005022 | null | null | Neo-adjuvant (N) | 2013-07-07 | 2013-07-29 | CISPLATIN + GEMCITABINE | N | N | 320022826 | BEVACIZUMAB |
| 320003485 | 320002106 | 1.7 | 57.8 | Palliative (P) | 2017-09-25 | 2017-10-02 | CARBOPLATIN + RT | 02 | N | 320022837 | CETUXIMAB + CISPLATIN + FU |
| 320003486 | 320002106 | 1.63 | 106.6 | Adjuvant (A) | 2015-10-31 | 2015-12-17 | IVA | N | Y | 320022837 | CARBOPLATIN + VINCRISTINE |
| 320003487 | 320002107 | 1.64 | null | Palliative (P) | 2015-10-29 | 2015-11-12 | Cisplatin + Docetaxel +Fluorouracil | N | N | 320022850 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 320003488 | 320002108 | 1.91 | 80.2 | Palliative (P) | 2017-07-26 | 2017-07-26 | Bevacizumab + Cape + Oxali 21day | 2 | N | 320022851 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 320003489 | 320002109 | null | 92.7 | Palliative (P) | 2018-01-19 | 2018-01-20 | Cisplatin+Gemcitabine (gallbladder) | N | N | 320022852 | CISPLATIN + GEMCITABINE |
| 320003490 | 320002109 | 1.68 | 91.8 | Palliative (P) | 2017-12-01 | 2017-12-08 | CETUXIMAB | N | N | 320022852 | CARBOPLATIN + ETOPOSIDE |
| 320003491 | 320002109 | 1.62 | 69.8 | Palliative (P) | 2018-01-30 | 2018-02-06 | Bevacizumab 7.5mg/kg | 02 | N | 320022852 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 320003492 | 320002109 | 1.7 | 71 | Palliative (P) | 2015-10-09 | 2015-10-15 | CETUXIMAB + RT | N | N | 320022852 | IMATINIB |
| 320003493 | 320007224 | 1.85 | 106.2 | Curative (C) | 2014-07-12 | 2014-07-12 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 320022860 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320003494 | 320002110 | 1.68 | null | Adjuvant (A) | 2013-05-30 | 2013-06-02 | Epirubicin | N | N | 320022861 | CISPLATIN + GEMCITABINE |
| 320003495 | 320002110 | null | 50.5 | Palliative (P) | null | 2017-07-02 | ICON8B TRIAL | null | null | 320022861 | CARBOPLATIN + VINCRISTINE |
| 320003496 | 320002110 | 1.59 | 104 | Curative (C) | null | 2015-09-03 | IMATINIB | 2 | N | 320022861 | IVADO |
| 320003497 | 320002111 | 0 | 73.5 | Adjuvant (A) | 2016-12-13 | 2017-01-05 | Cisplatin + Etoposide (3 day) | 2 | Y | 320022876 | CISPLATIN + PEMETREXED |
| 320003498 | 320002112 | 1.56 | 79.7 | Palliative (P) | 2018-04-04 | 2018-04-22 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 320022880 | CARBOPLATIN + LIPOSOMAL DOX |
| 320003499 | 320002113 | 1.64 | null | null | null | 2013-10-07 | Doxorubicin + Ifosfamide | null | null | 320022881 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320003500 | 320002114 | 1.72 | 98 | Palliative (P) | 2017-12-31 | 2018-01-02 | EC | N | N | 320022888 | BEVACIZUMAB + CAPE + OXALIPLATIN |